CLINICAL_TRIALS
ClinicalTrials.gov record update
An fMRI Study of Treatment Optimization Recommendations Comparing Patients Changing Treatment From Glatiramer Acetate 20 mg qd SC (Copaxone®) to IFN-β-1a 30 Mcg qw IM (Avonex®) to Those Changing From to IFN-β-1a 30 Mcg qw IM (Avonex®) to Glatiramer Acetate 20 mg qd SC (Copaxone®) in a Multicenter Study of Patients With Relapsing Remitting Multiple Sclerosis Currently on Disease-Modifying Therapy.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00398528
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:34:53.428608+00:00
- Published At
- 2007-12-05T00:00:00+00:00
- Record Updated At
- 2007-12-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Relapsing-Remitting Multiple Sclerosis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2007-12-05"- protocolSection.identificationModule.nctId
"NCT00398528"- protocolSection.identificationModule.officialTitle
"An fMRI Study of Treatment Optimization Recommendations Comparing Patients Changing Treatment From Glatiramer Acetate 20 mg qd SC (Copaxone\u00ae) to IFN-\u03b2-1a 30 Mcg qw IM (Avonex\u00ae) to Those Changing From to IFN-\u03b2-1a 30 Mcg qw IM (Avonex\u00ae) to Glatiramer Acetate 20 mg qd SC (Copaxone\u00ae) in a Multicenter Study of Patients With Relapsing Remitting Multiple Sclerosis Currently on Disease-Modifying Therapy."- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.